The Newcastle upon Tyne Hospitals NHS Foundation Trust: Contract for the supply of aCGH slides and associated Analyser

UK-Newcastle upon Tyne: Laboratory reagents.

Preliminary Questions
   This notice is published by:
   Directive 2014/25/EU

Section I: Contracting authority/entity

I.1) Name and addresses
       The Newcastle upon Tyne Hospitals NHS Foundation Trust
       Regent Point, Regent Farm Road, Newcastle upon Tyne, NE3 3HD, United Kingdom
       Tel. +44 1912137524, Email: owen.oreilly@nhs.net
       Contact: Owen OReilly
       Main Address: https://www.delta-esourcing.com/, Address of the buyer profile: https://www.newcastle-hospitals.nhs.uk/
       NUTS Code: UKC22


I.6) Main Activity (in the case of a notice published by a contracting entity)
      Other activity:

Section II: Object

II.1) Scope of the procurement
   
   II.1.1) Title: Contract for the supply of aCGH slides and associated Analyser.
      Reference number: T/2021/007
      
   II.1.2) Main CPV code:
      33696500 - Laboratory reagents.
   
   II.1.3) Type of contract: SUPPLIES
   
   II.1.4) Short Description: Contract for the supply of aCGH slides and associated Analyser with maintenance and support included for a period of 24 months with the option to extend for a further 2 x 12 months
   
   II.1.6) Information about lots
      This contract is divided into lots: No

   II.1.7) Total value of the procurement (excluding VAT)
      Value: 1,069,985      
      Currency: GBP


II.2) Description

   II.2.2) Additional CPV codes:
      Not provided

   II.2.3) Place of performance:
      UKC22 Tyneside
   
   
   II.2.4) Description of the procurement:
    Contract for the supply of aCGH slides and associated Analyser with maintenance and support included for a period of 24 months with the option to extend for a further 2 x 12 months    
   
   II.2.5) Award criteria
   (Directive 2014/24/EU / Directive 2014/25/EU)
               
    Not provided       
      
      
   II.2.11) Information about options:
      Options:    No       
   
   II.2.13) Information about European Union funds:
      The procurement is related to a project and/or programme financed by European Union funds:    No

   II.2.14) Additional information:
    Not provided    
      
Section IV: Procedure

IV.1) Description
   
   IV.1.1) Type of procedure: Award of a contract without prior publication of a call for competition in the Official Journal of the European Union in the cases listed below         
   
   IV.1.3) Information about framework agreement
         The procurement involves the establishment of a framework agreement: No    
   
   IV.1.8) Information about the Government Procurement Agreement (GPA)
         The procurement is covered by the Government Procurement Agreement:Yes
         
IV.2)Administrative Information

   IV.2.1) Previous publication concerning this procedure:
      Notice number in OJ S: 2014/S 108 - 189882       
   
Section V: Award Of Contract/Concession
      
Award of Contract/Concession No: 1
Contract No: T/2021/007   Lot Number: Not Provided    Title: Contract for the supply of aCGH slides and associated Analyser

V.2) Award of contract/concession
      
      V.2.1) Date of contract award decision: 24/02/2021.
      
      V.2.2) Information about tenders
      The contract has been awarded to a group of economic operators: No .

      V.2.3) Name and address of the contractor/concessionaire, No. 1:
          ILLUMINA CAMBRIDGE LIMITED, 03625145
       19 Granta Park, Great Abington, Cambridge, CB216DF, United Kingdom
       Tel. +44 7748335203, Email: rjowsey@illumina.com
       Internet address: www.illumina.com
       NUTS Code: UKC22
   The contractor/concessionaire will be an SME: No    
   
         
      V.2.4) Information on value of the contract/lot/concession:
         Initial estimated total value of the contract: 1,283,982          
         Total value of the contract/lot/concession 1,069,985         
         Currency: GBP

      V.2.5) Information about subcontracting:
         The contract is likely to be subcontracted: No          


Section VI: Complementary Information

   VI.3) Additional Information:
      To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=573609084
GO-2021225-PRO-17843462 TKR-2021225-PRO-17843461   
   VI.4) Procedures for review
   
      VI.4.1) Review Body
          The Newcastle upon Tyne Hospitals NHS Foundation Trust
       Regent Point, Regent Farm Road, Newcastle upon Tyne, NE3 3HD, United Kingdom
       Tel. +44 1912137524, Email: owen.oreilly@nhs.net
       Internet address: https://www.newcastle-hospitals.nhs.uk/
   
      V1.4.2) Body responsible for mediation procedures:
                The Newcastle upon Tyne Hospitals NHS Foundation Trust
       Freeman Hospitals Headquarters, Freeman Road, High Heaton, Newcastle upon Tyne, NE77DN, United Kingdom
       Tel. +44 1912336161
       Internet address: https://www.newcastle-hospitals.nhs.uk/.

      VI.4.3) Review procedure
      Not Provided    
      
      VI.4.4) Service from which information about the review procedure may be obtained
         Not Provided
   
   VI.5) Date of dispatch of this notice: 25/02/2021


Annex D2 - Utilities
Justification for the award of the contract without prior publication of a call for competition in the Official Journal of the European Union
Directive 2014/25/EU


2. Other justification for the award of the contract without prior publication of a call for competition in the Official Journal of the European Union

   The procurement falls outside the scope of application of the directive: Yes
3. Explanation

   Please explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union is
   lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive: (500 words maximum)
   Characteristic patterns of DNA methylation of CpG islands in the genome are key features in various paediatric and adult solid tumours.

The Illumina iScan is the only scanning platform which allows genome-wide methylation studies using the Infinium Methylation EPIC BeadChip.

The Illumina 850k EPIC array assesses the DNA methylation status of a small proportion of the 850,000 individual CpG sites on the array.

Illumina 850k CytoSNP BeadChips require use of either NextSeq 500/550 or iScan scanners – no other scanners will work with the BeadChips

An algorithm, developed at the DKFZ in Heidelberg, Germany, is able to distinguish brain tumour entities based on their methylation profile using this platform (Capper et al. Nature. 2018 March 22; 555(7697): 469–474).

This internationally recognised classifier is necessary to deliver accurate diagnosis for paediatric and adult tumours within the Yorkshire and North East GLH region through the new National Genomic Test Directory.